Literature DB >> 21270152

Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate.

Kazuaki Monde1, Vineela Chukkapalli, Akira Ono.   

Abstract

HIV-1 Gag assembles into virus particles predominantly at the plasma membrane (PM). Previously, we observed that phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P(2)] is essential for Gag binding to the plasma membrane and virus release in HeLa cells. In the current study, we found that PI(4,5)P(2) also facilitates Gag binding to the PM and efficient virus release in T cells. Notably, serial passage of HIV-1 in an A3.01 clone that expresses polyphosphoinositide 5-phosphatase IV (5ptaseIV), which depletes cellular PI(4,5)P(2), yielded an adapted mutant with a Leu-to-Arg change at matrix residue 74 (74LR). Virus replication in T cells expressing 5ptaseIV was accelerated by the 74LR mutation relative to replication of wild type HIV-1 (WT). This accelerated replication of the 74LR mutant was not due to improved virus release. In control T cells, the 74LR mutant releases virus less efficiently than does the WT, whereas in cells expressing 5ptaseIV, the WT and the 74LR mutant are similarly inefficient in virus release. Unexpectedly, we found that the 74LR mutation increased virus infectivity and compensated for the inefficient virus release. Altogether, these results indicate that PI(4,5)P(2) is essential for Gag-membrane binding, targeting of Gag to the PM, and efficient virus release in T cells, which in turn likely promotes efficient virus spread in T cell cultures. In T cells with low PI(4,5)P(2) levels, however, the reduced virus particle production can be compensated for by a mutation that enhances virus infectivity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270152      PMCID: PMC3067840          DOI: 10.1128/JVI.02266-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  The N-terminal basic domain of the HIV-1 matrix protein does not contain a conventional nuclear localization sequence but is required for DNA binding and protein self-association.

Authors:  Anna C Hearps; Kylie M Wagstaff; Sabine C Piller; David A Jans
Journal:  Biochemistry       Date:  2008-01-29       Impact factor: 3.162

2.  Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.

Authors:  Anjali Joshi; Sherimay D Ablan; Ferri Soheilian; Kunio Nagashima; Eric O Freed
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

3.  Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.

Authors:  Janet L Douglas; Kasinath Viswanathan; Matthew N McCarroll; Jean K Gustin; Klaus Früh; Ashlee V Moses
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

4.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

5.  Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail.

Authors:  Ajay K Bhatia; Rajnish Kaushik; Nancy A Campbell; Suzanne E Pontow; Lee Ratner
Journal:  Virology       Date:  2008-12-06       Impact factor: 3.616

6.  Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding.

Authors:  Vineela Chukkapalli; Ian B Hogue; Vitaly Boyko; Wei-Shau Hu; Akira Ono
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

7.  Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides.

Authors:  Robin Chan; Pradeep D Uchil; Jing Jin; Guanghou Shui; David E Ott; Walther Mothes; Markus R Wenk
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

8.  HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate.

Authors:  Ayna Alfadhli; Robin Lid Barklis; Eric Barklis
Journal:  Virology       Date:  2009-03-27       Impact factor: 3.616

9.  Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.

Authors:  Jamil S Saad; Sherimay D Ablan; Ruba H Ghanam; Andrew Kim; Kalola Andrews; Kunio Nagashima; Ferri Soheilian; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2008-07-16       Impact factor: 5.469

10.  Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

Authors:  Richard S Mitchell; Chris Katsura; Mark A Skasko; Katie Fitzpatrick; David Lau; Autumn Ruiz; Edward B Stephens; Florence Margottin-Goguet; Richard Benarous; John C Guatelli
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more
  22 in total

Review 1.  How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.

Authors:  Jaisri R Lingappa; Jonathan C Reed; Motoko Tanaka; Kasana Chutiraka; Bridget A Robinson
Journal:  Virus Res       Date:  2014-07-24       Impact factor: 3.303

2.  HIV-1 matrix protein binding to RNA.

Authors:  Ayna Alfadhli; Henry McNett; Seyram Tsagli; Hans Peter Bächinger; David H Peyton; Eric Barklis
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

Review 3.  Molecular determinants that regulate plasma membrane association of HIV-1 Gag.

Authors:  Vineela Chukkapalli; Akira Ono
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

4.  Host Cell Plasma Membrane Phosphatidylserine Regulates the Assembly and Budding of Ebola Virus.

Authors:  Emmanuel Adu-Gyamfi; Kristen A Johnson; Mark E Fraser; Jordan L Scott; Smita P Soni; Keaton R Jones; Michelle A Digman; Enrico Gratton; Charles R Tessier; Robert V Stahelin
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

5.  Molecular Determinants in tRNA D-arm Required for Inhibition of HIV-1 Gag Membrane Binding.

Authors:  Christopher Sumner; Osamu Kotani; Shuohui Liu; Karin Musier-Forsyth; Hironori Sato; Akira Ono
Journal:  J Mol Biol       Date:  2021-12-06       Impact factor: 5.469

6.  Molecular Determinants Directing HIV-1 Gag Assembly to Virus-Containing Compartments in Primary Macrophages.

Authors:  Jingga Inlora; Vineela Chukkapalli; Sukhmani Bedi; Akira Ono
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 7.  Roles played by acidic lipids in HIV-1 Gag membrane binding.

Authors:  Balaji Olety; Akira Ono
Journal:  Virus Res       Date:  2014-07-03       Impact factor: 3.303

8.  HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.

Authors:  Raymond A Alvarez; Rebecca E Hamlin; Anthony Monroe; Brian Moldt; Mathew T Hotta; Gabriela Rodriguez Caprio; Daniel S Fierer; Viviana Simon; Benjamin K Chen
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

9.  Analysis of small molecule ligands targeting the HIV-1 matrix protein-RNA binding site.

Authors:  Ayna Alfadhli; Henry McNett; Jacob Eccles; Seyram Tsagli; Colleen Noviello; Rachel Sloan; Claudia S López; David H Peyton; Eric Barklis
Journal:  J Biol Chem       Date:  2012-11-07       Impact factor: 5.157

Review 10.  PIP2: choreographer of actin-adaptor proteins in the HIV-1 dance.

Authors:  Vera Rocha-Perugini; Mónica Gordon-Alonso; Francisco Sánchez-Madrid
Journal:  Trends Microbiol       Date:  2014-04-23       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.